Basilea PharmaceuticaBSLN 
$52.37-0.78%24h
-0.78%24h
Global rank10114
Market cap$627.96M
Change 7d-1.22%
YTD Performance25.11%
SP500 benchmarkOutperform
P/E60.89
P/S3.37
Revenue$186.13M
Earnings$12.34M
Dividend yield-
Market capitalization of Basilea Pharmaceutica (BSLN)
As of November 2024, Basilea Pharmaceutica has a market cap of $627.96M. This makes Basilea Pharmaceutica the world's 10114th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Basilea Pharmaceutica from 2004 to 2024
-
Value:-
Market cap history of Basilea Pharmaceutica from 2004 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $529.55M | 5.95% |
| 2023 | $499.82M | -22.93% |
| 2022 | $648.49M | 11.93% |
| 2021 | $579.39M | -23.01% |
| 2020 | $752.56M | 13.42% |
| 2019 | $663.50M | 17.27% |
| 2018 | $565.80M | -47.35% |
| 2017 | $1.07B | 3.83% |
| 2016 | $1.04B | -24.09% |
| 2015 | $1.36B | 4.50% |
| 2014 | $1.30B | -12.57% |
| 2013 | $1.49B | 136.32% |
| 2012 | $631.50M | 24.93% |
| 2011 | $505.48M | -45.08% |
| 2010 | $920.35M | 0.85% |
| 2009 | $912.56M | -56.72% |
| 2008 | $2.11B | -32.47% |
| 2007 | $3.12B | 4.24% |
| 2006 | $3.00B | 53.24% |
| 2005 | $1.95B | 53.59% |
| 2004 | $1.27B | - |
BSLN Market Cap Today is $627.96M -0.78% - 17 Nov 2024
View largest stocks by market cap 
